Results 51 to 60 of about 7,433 (204)

Seroprevalence Screening of Chronic Aspergillus Infection in a Post‐Tuberculosis Cohort in Senegal: A Cross‐Sectional Study Comparing ELISA and Rapid Diagnostic Tests

Mycoses, Volume 69, Issue 4, April 2026.
ABSTRACT Background Chronic pulmonary aspergillosis (CPA) is a significant, yet often overlooked, sequela of pulmonary tuberculosis (TB), particularly in resource‐limited settings. Data on the seroprevalence of Aspergillus infection in Senegal is absent, and diagnostic capacity is limited. This study aimed to determine the seroprevalence of Aspergillus‐
Touré Mariama, Ndiaye Ibrahima Mbaye, Sow Djiby, Diallo Mamadou Alpha, Diongue Khadim, Seck Mame Cheikh, Ndiaye Mouhamadou, Ndiaye Daouda, Ndiaye Faly Diop, Fortes Louise, Denning David, Badiane Aida Sadikh   +11 more
wiley   +1 more source

Unraveling the Complexities of Kartagener's Syndrome: A Case of Bronchiectasis, Isolated Dextrocardia, and Primary Ciliary Dyskinesia in an Adult With Chronic Respiratory Symptoms

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Kartagener's Syndrome (KS), a rare autosomal recessive disorder and a subset of Primary Ciliary Dyskinesia (PCD), is characterized by chronic sinusitis, bronchiectasis, and, in approximately 50% of cases, situs inversus. This condition arises from genetic mutations that impair motile cilia function, leading to defective mucociliary clearance ...
Ibrahim Khalil, Sakib Abrar, Shah Tanvir Ahmed, Md. Imran Hossain   +3 more
wiley   +1 more source

New Allergens Approved by the WHO/IUIS Allergen Nomenclature Sub‐Committee in 2021–2024 and Their Significance for Future Diagnostics, Regulation, and Research. An EAACI Task Force Report

Allergy, Volume 81, Issue 3, Page 684-699, March 2026.
ABSTRACT The WHO/IUIS Allergen Nomenclature Sub‐Committee is an international body of experts that maintains the systematic nomenclature of allergenic proteins by assigning official names to newly identified allergens submitted by researchers. Here, we summarize the data on new allergens approved between 2021 and 2024.
Christian Radauer, Gabriele Gadermaier, Richard E. Goodman, Alain Jacquet, Uta Jappe, Andreas L. Lopata, Anna Pomés, Monika Raulf, Keity S. Santos, Josefina Zakzuk, Yuzhu Zhang, Joana Vitte, on behalf of the WHO/IUIS Allergen Nomenclature Sub‐Committee   +12 more
wiley   +1 more source

Estimated Burden of Serious Fungal Infections in Mozambique

Journal of Fungi, 2018
Mozambique is a sub-Saharan African country with limited information on the burden of fungal disease. We estimate the burden of serious fungal infections for the general healthy population and for those at risk, including those infected with HIV ...
Jahit Sacarlal, David W. Denning
doaj   +1 more source

Asthma and aspergillosis: Which One causes another

Biomedical and Biotechnology Research Journal, 2020
The respiratory system of the human body is always under exposure to a great number of fungal spores every day. Asexual spores of Aspergillus are the most frequent type occurring in various environments.
Roaa Noori Ali, Ali Abdul Hussein S. Al-Janabi   +1 more
doaj   +1 more source

Serum level directed itraconazole therapy in allergic bronchopulmonary aspergillosis

, 2016
Background Itraconazole (ITZ) is an alternative to steroids in the treatment of allergic bronchopulmonary aspergillosis (ABPA) but therapeutic drug monitoring (TDM) is warranted due to erratic absorption and early relapse.
Agarwal, Kshitij, S.N. Gaur, Kshitij Agarwal, Anuradha Chowdhary, Roger Bruggemann, Meis, J.F., Bruggemann, Roger, Gaur, S.N., Chowdhary, Anuradha, J.F. Meis   +9 more
core   +1 more source

Severe Allergic Bronchopulmonary Mycosis and Long-Term Follow-Up

Case Reports in Immunology, 2018
Allergic bronchopulmonary aspergillosis (ABPA) is the most common immunologic reaction following fungal allergen exposure in asthmatic patients. A less frequent syndrome in response to other fungal species like candida is allergic bronchopulmonary ...
Hossein Esmaeilzadeh, Sara Kashef, Hamid Reza Hatami, Soheila Alyasin, Hesamodin Nabavizadeh, Elmira Esmaeilzadeh   +5 more
doaj   +1 more source

Allergic bronchopulmonary aspergillosis mimicking miliary tuberculosis

Egyptian Journal of Chest Disease and Tuberculosis, 2018
Tuberculosis (TB) continues to be a major global health problem, especially in developing countries such as Indonesia. TB makes the individual more susceptible to other diseases caused by other microorganisms.
Gurmeet Singh, Nova B Fauzi, Alvina Widhani   +2 more
doaj   +1 more source

Impact of Prior Intravenous Immunoglobulin and Plasmapheresis on Eculizumab or Ravulizumab Treatment for Generalized Myasthenia Gravis: An Analysis of the MG SPOTLIGHT Registry

Clinical and Experimental Neuroimmunology, Volume 17, Issue 1, February 2026.
ABSTRACT Objective The complement component 5 inhibitor therapies (C5ITs) eculizumab and ravulizumab are approved for the treatment of generalized myasthenia gravis (gMG). We evaluated the real‐world effectiveness and safety of eculizumab and ravulizumab in patients with gMG with or without prior intravenous immunoglobulin (IVIg) or plasma exchange ...
Akiyuki Uzawa, Ema Rodrigues, Hiroyuki Murai   +2 more
wiley   +1 more source

Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

, 2018
Moshe Ashkenazi,1,2 Saray Sity,2 Ifat Sarouk,1,2 Bat El Bar Aluma,1,2 Adi Dagan,1,2 Yael Bezalel,1,2 Lea Bentur3 Kris De Boeck,4 Ori Efrati1,2 1Pediatric Pulmonology and National CF Center,
Sarouk I, Bentur L, Bar Aluma BE, De Boeck K, Efrati O, Bezalel Y, Ashkenazi M, Sity S, Dagan A   +8 more
core